A US district court has said that a key patent held by Astellas on its Myrbetriq drug for urinary incontinence is invalid, in a setback to its efforts to defend the blockbuster therapy from ...
Muscarinic receptor antagonists are the mainstay of medical therapy for overactive bladder and urgency urinary incontinence, and as a class appear to be effective in the elderly. These drugs are ...
According to the researchers, the benefits are comparable to the effects of incontinence medications. “Our study was testing the kind of yoga that just about anyone can do, with modifications ...
GlobalData’s report assesses the drugs in the Insulin Like Growth Factor I pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.